- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03245723
Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI) (PET-MRI)
February 2, 2021 updated by: University of Wisconsin, Madison
Cardiac Function and Metabolism in Young Adults Born Premature
The purpose of this research is to determine the effect of premature birth on later heart function and metabolism.
Study Overview
Status
Completed
Conditions
Detailed Description
The purpose of this study is to determine the effects of premature birth on cardiac function, cardiac metabolism, and oxidative stress in a cohort of young adults born prematurely using cardiac positron emission tomography/magnetic resonance imaging and mitochondrial respiration studies.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- UW Madison
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- National Lung Project Cohort only- birth weight <1500g and a gestational age <36 weeks
- Adults born preterm (Non-National Lung Project) only- gestational age ≤32 weeks OR birth weight ≤ 3lbs 5oz
- Healthy Controls only- No personal history of known cardiovascular or pulmonary disease
Exclusion Criteria:
- Metabolic Disorders that would affect Fludeoxyglucose uptake
- Contraindications to positron emission tomography and/or magnetic resonance imaging
- Pregnancy, if a female of child-bearing potential
- A personal history of Type I or Type II diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Preterm
Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. |
Subjects will undergo an electrocardiogram to ensure sinus rhythm
Subjects will undergo Spirometry and Plethysmography
Subjects will undergo positron emission tomography to detect images of the heart
Subjects will undergo positron magnetic resonance imaging to detect images of the heart
|
Placebo Comparator: Term - Healthy Controls
Healthy individuals that were not born premature.
Individuals are ages 18-35.
Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
|
Subjects will undergo an electrocardiogram to ensure sinus rhythm
Subjects will undergo Spirometry and Plethysmography
Subjects will undergo positron emission tomography to detect images of the heart
Subjects will undergo positron magnetic resonance imaging to detect images of the heart
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac Glucose Uptake During Normoxic Rest (µg/Min)
Time Frame: Visit 1 (1 day)
|
Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.
|
Visit 1 (1 day)
|
Change in Glucose Uptake From Normoxia to Hypoxia (µg/Min)
Time Frame: Visit 1 (1 day)
|
Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.
|
Visit 1 (1 day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kara N Goss, MD, The University of Wisconsin School of Medicine and Public Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2017
Primary Completion (Actual)
February 26, 2020
Study Completion (Actual)
February 26, 2020
Study Registration Dates
First Submitted
August 8, 2017
First Submitted That Met QC Criteria
August 8, 2017
First Posted (Actual)
August 10, 2017
Study Record Updates
Last Update Posted (Actual)
February 4, 2021
Last Update Submitted That Met QC Criteria
February 2, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-0238
- A534285 (Other Identifier: UW Madison)
- SMPH/MEDICINE/MEDICINE*P (Other Identifier: University of Wisconsin-Madison)
- UL1TR000427 (U.S. NIH Grant/Contract)
- Protocol Version 4/23/2019 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant,Premature
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico
Clinical Trials on Electrocardiogram
-
University of CambridgeUniversity of Leicester; City, University of LondonRecruitingAtrial Fibrillation | Paroxysmal Atrial FibrillationUnited Kingdom
-
Ain Shams UniversityRecruitingWolf Parkinson White Syndrome | ArrythmiasEgypt
-
Khon Kaen UniversityRecruitingCardiovascular Diseases | Arrhythmias, Cardiac | COVID-19 Acute Respiratory Distress SyndromeThailand
-
Garmin InternationalCompleted
-
University Hospital, MontpellierTerminated
-
Assiut UniversityUnknownDiabetes Mellitus, Type 1
-
Population Health Research InstituteHamilton Health Sciences CorporationCompletedAtrial Fibrillation New OnsetCanada
-
Cardiovascular Academy Society, TurkeyCompletedLeft Ventricular HypertrophyTurkey
-
University of Toledo Health Science CampusCompletedElectrocardiographyUnited States